Highlights from IOHK 2024 by Herbert Loong
Immuno-Oncology Hong Kong 2024 Conference was held from November 23-24, 2024.
IOHK 2024 was hosted by the Department of Clinical Oncology and Hong Kong Cancer Institute at The Chinese University of Hong Kong. The conference focused on the latest advancements in immuno-oncology, exploring topics such as immune checkpoint inhibitors, CAR-T therapies, and personalized cancer treatments. Experts discussed challenges like immune resistance, side effects, and the integration of immunotherapy with traditional treatments. It served as a key platform for sharing research, discussing clinical trial data, and fostering global collaborations in cancer immunotherapy.
Herbert Loong, the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO), shared about this conference on X:
Kelvin Yan sharing insights on developing ADCs
“Our CUHK Department of Clinical Oncology’s very own Kelvin Yan sharing with us his insights on developing ADCs in genitourinary cancers at IOHK 2024.”
Maxillian Diehn discussed the current status and development of liquid biopsies
“Next up was Maxillian Diehn of Stanford Medicine – a true leader and visionary of ctDNA and MRD testing who discussed the current status and development of liquid biopsies for monitoring in lung cancer patients.”
Daniel Sterman’s insights on lung cancer
“Thanks Daniel Sterman for sharing with us his experiences and insights on how local therapies and synergize and potentiate systemic therapies in lung cancer. Lots to learn in this field and true area for multidisciplinary collaborations.”
“We are also excited to welcome fellow APODDC Scientific Committee member Dr. Seehoon Park from Samsung Medical Center to CUHK.”
Welcoming Antonio Passaro and Jürgen Wolf
“Delighted to be able to welcome Antonio Passaro and Prof. Jürgen Wolf over the last 2 days as speakers at various symposiums during.”
Thoracic oncologists in the car
“How many thoracic oncologists from around the world can fit in my car? Guess it’s a steering committee. Thanks Peters Solange, Jonathan Spicer, Antonio Passaro, Pasi Jänne for coming to Hong Kong and for supporting IOHK24.”
Landon Chan’s overview on combination of locoregional therapies
“Our very own Landon Chan giving an excellent overview on combination of locoregional therapies and immunotherapy in HCC.”
Session on hepatocellular carcinoma
“Sitting through a very interesting session on hepatocellular carcinoma and biliary tract cancer at IOHK2024. Thanks Angela Lamarca, Prof Ming Kuang and Prof Ardnt Vogel for your insights!”
The end of lung cancer session
“Excellent discussions at the end of lung cancer session of IOHK2024 on how best to tailor and prioritise perioperative treatments. Neoadj IO in EGFR positive pts not recommended!”
Jonathan Spicer’s surgeon’s perspective
“Thanks Jonathan Spicer for sharing his surgeon’s perspective on the role of peri-operative chemotherapy and immunotherapy in the management of lung cancer.”
“Thrilled to have Pasi Jänne from Dana Farber Cancer Center come all the way to Hong Kong to speak at our IOHK2024 conference this weekend!”
For more information, visit oncodaily.com.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023